Skip to main content
. 2023 Nov 22;15(23):5510. doi: 10.3390/cancers15235510

Figure 8.

Figure 8

PARP1 expression in BCR::ABL1 p190+ patient samples. (A) Pooled analysis of the average fold change of PARP1 expression in ALL p190+ patient samples. (B) Pooled analysis of the average fold change of PARP1 expression in CML p190+ patient samples. (C) PARP1 expression in cohorts of ALL patients from the GSE13159 dataset. Healthy blood donors were used as comparative controls. Statistical differences were analyzed through the Student’s T-test or the Wilcoxon test. ALL: Acute lymphoblastic leukemia; C-ALL: Childhood Acute Lymphoblastic Leukemia; CML: Chronic myeloid leukemia; ns: Not significant; ** p < 0.01; *** p < 0.0001.